Connection

PRAKASH MASAND to Antipsychotic Agents

This is a "connection" page, showing publications PRAKASH MASAND has written about Antipsychotic Agents.
Connection Strength

2.464
  1. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting. Int Clin Psychopharmacol. 2014 Mar; 29(2):116-9.
    View in: PubMed
    Score: 0.337
  2. Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data. Schizophr Res. 2011 Mar; 126(1-3):174-83.
    View in: PubMed
    Score: 0.270
  3. Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010). Psychopharmacol Bull. 2008; 41(2):12-23.
    View in: PubMed
    Score: 0.220
  4. Differential pharmacology of atypical antipsychotics: clinical implications. Am J Health Syst Pharm. 2007 Jan 15; 64(2 Suppl 1):S3-8; quiz S24-5.
    View in: PubMed
    Score: 0.206
  5. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol. 2006 Jan; 1(1):47-56.
    View in: PubMed
    Score: 0.191
  6. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization. CNS Spectr. 2005 Oct; 10(10):suppl14 1-15.
    View in: PubMed
    Score: 0.188
  7. Second-generation antipsychotics and the metabolic syndrome. Curr Psychiatry Rep. 2005 Jun; 7(3):153-4.
    View in: PubMed
    Score: 0.184
  8. Clinical effectiveness of atypical antipsychotics in elderly patients with psychosis. Eur Neuropsychopharmacol. 2004 Nov; 14 Suppl 4:S461-9.
    View in: PubMed
    Score: 0.177
  9. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Drugs Aging. 2003; 20(15):1099-110.
    View in: PubMed
    Score: 0.155
  10. Prescribing conventional antipsychotics in the era of novel antipsychotics: informed consent issues. Am J Ther. 2002 Nov-Dec; 9(6):484-7.
    View in: PubMed
    Score: 0.154
  11. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials. J Affect Disord. 2019 10 01; 257:600-606.
    View in: PubMed
    Score: 0.122
  12. A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. J Clin Psychopharmacol. 2015 Jun; 35(3):319-23.
    View in: PubMed
    Score: 0.092
  13. A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state. PLoS One. 2012; 7(4):e34757.
    View in: PubMed
    Score: 0.074
  14. Clinical variables associated with early administration of antipsychotics in bipolar mania. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan; 30(1):151-4.
    View in: PubMed
    Score: 0.047
  15. Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison. Int Clin Psychopharmacol. 2017 09; 32(5):235-248.
    View in: PubMed
    Score: 0.027
  16. Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics. Clin Neuropharmacol. 2013 Nov-Dec; 36(6):223-38.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.